Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 22700 | 316 | 41.7 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PUR ALPHA | Author keyword | 55 | 87% | 9% | 27 |
| 2 | TEF 1 | Author keyword | 7 | 56% | 3% | 9 |
| 3 | RTEF 1 | Author keyword | 6 | 80% | 1% | 4 |
| 4 | SCALLOPED | Author keyword | 6 | 50% | 3% | 9 |
| 5 | TRANSCRIPTIONAL ENHANCER FACTOR 1 | Author keyword | 4 | 67% | 1% | 4 |
| 6 | PUR BETA | Author keyword | 4 | 75% | 1% | 3 |
| 7 | PURA | Author keyword | 3 | 50% | 2% | 5 |
| 8 | TRANSCRIPTION ENHANCER FACTOR 1 | Author keyword | 3 | 100% | 1% | 3 |
| 9 | VESTIGIAL LIKE | Author keyword | 2 | 67% | 1% | 2 |
| 10 | NEUROVIROL NEUROONCOL | Address | 2 | 19% | 3% | 8 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | PUR ALPHA | 55 | 87% | 9% | 27 | Search PUR+ALPHA | Search PUR+ALPHA |
| 2 | TEF 1 | 7 | 56% | 3% | 9 | Search TEF+1 | Search TEF+1 |
| 3 | RTEF 1 | 6 | 80% | 1% | 4 | Search RTEF+1 | Search RTEF+1 |
| 4 | SCALLOPED | 6 | 50% | 3% | 9 | Search SCALLOPED | Search SCALLOPED |
| 5 | TRANSCRIPTIONAL ENHANCER FACTOR 1 | 4 | 67% | 1% | 4 | Search TRANSCRIPTIONAL+ENHANCER+FACTOR+1 | Search TRANSCRIPTIONAL+ENHANCER+FACTOR+1 |
| 6 | PUR BETA | 4 | 75% | 1% | 3 | Search PUR+BETA | Search PUR+BETA |
| 7 | PURA | 3 | 50% | 2% | 5 | Search PURA | Search PURA |
| 8 | TRANSCRIPTION ENHANCER FACTOR 1 | 3 | 100% | 1% | 3 | Search TRANSCRIPTION+ENHANCER+FACTOR+1 | Search TRANSCRIPTION+ENHANCER+FACTOR+1 |
| 9 | VESTIGIAL LIKE | 2 | 67% | 1% | 2 | Search VESTIGIAL+LIKE | Search VESTIGIAL+LIKE |
| 10 | BETA E3 DNA REGULATORY ELEMENT | 1 | 100% | 1% | 2 | Search BETA+E3+DNA+REGULATORY+ELEMENT | Search BETA+E3+DNA+REGULATORY+ELEMENT |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENHANCER FACTOR I | 27 | 43% | 15% | 48 |
| 2 | TEF 1 | 24 | 68% | 7% | 21 |
| 3 | CAT BINDING FACTOR | 20 | 67% | 6% | 18 |
| 4 | FACTOR I TEF 1 | 19 | 80% | 4% | 12 |
| 5 | MCAT ENHANCER | 18 | 89% | 3% | 8 |
| 6 | FACTOR RTEF 1 | 14 | 100% | 2% | 7 |
| 7 | SOMATOMAMMOTROPIN GENE ENHANCER | 14 | 100% | 2% | 7 |
| 8 | M CAT ELEMENTS | 11 | 60% | 4% | 12 |
| 9 | TRANSCRIPTION FACTOR RTEF 1 | 9 | 83% | 2% | 5 |
| 10 | VG FUNCTION | 8 | 100% | 2% | 5 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| MCAT elements and the TEF-1 family of transcription factors in muscle development and disease | 2008 | 33 | 83 | 65% |
| Multiple roles for Pur alpha in cellular and viral regulation | 2009 | 5 | 90 | 63% |
| The Role of Transcription Enhancer Factors in Cardiovascular Biology | 2011 | 2 | 46 | 63% |
| The pur protein family: Genetic and structural features in development and disease | 2013 | 2 | 107 | 41% |
| Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression | 1996 | 31 | 72 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NEUROVIROL NEUROONCOL | 2 | 19% | 2.5% | 8 |
| 2 | CARDIOVASC LIFE SCI | 1 | 50% | 0.6% | 2 |
| 3 | DH RUTTENBERG CANC | 1 | 30% | 0.9% | 3 |
| 4 | MOL NEUROVIROL | 1 | 17% | 1.3% | 4 |
| 5 | COMM MOL MED PATHOL | 1 | 50% | 0.3% | 1 |
| 6 | GENET QUANTITAT MOL | 1 | 50% | 0.3% | 1 |
| 7 | POLLY ANNENBERG LEVEE HEMATOL | 1 | 50% | 0.3% | 1 |
| 8 | SURG CARDIAC THORAC | 1 | 50% | 0.3% | 1 |
| 9 | BROOKDALE MOL DEV BIOL | 1 | 29% | 0.6% | 2 |
| 10 | FREDERICK CANC DEV MAMMALIAN GENET | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000135092 | HIPPO PATHWAY//YAP//HIPPO |
| 2 | 0.0000131460 | GH 1 GENE//PLACENTAL GROWTH HORMONE//HUMAN PLACENTAL GROWTH HORMONE |
| 3 | 0.0000121990 | SERUM RESPONSE FACTOR//MYOCARDIN//SRF |
| 4 | 0.0000117849 | YB 1//Y BOX BINDING PROTEIN 1//Y BOX PROTEIN |
| 5 | 0.0000111511 | LEG DEVELOPMENT//VESTIGIAL//HOMOTHORAX |
| 6 | 0.0000102811 | TRANSLIN//TRAX//TB RBP |
| 7 | 0.0000097554 | VENTRICULAR MYOSIN HEAVY CHAIN//PRIMORDIAL PHENOTYPE//CONTRACTILE PROTEIN GENES |
| 8 | 0.0000079846 | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY//JC VIRUS//PROGRESSIVE MULTIFOCAL |
| 9 | 0.0000069692 | DERMOMYOTOME//MYF5//MYOD |
| 10 | 0.0000067355 | ANTI THY 12 ANTIBODY//CELL TYPE IDENTITY//ENHANCER CORE |